John Milligan
Vorsitzender bei PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von John Milligan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Independent Dir/Board Member | 18.07.2013 | - |
| Vorsitzender | 14.09.2020 | - | |
| Direktor/Vorstandsmitglied | 18.07.2013 | 14.09.2020 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Vorsitzender | 01.08.2020 | - |
| Independent Dir/Board Member | 01.08.2020 | - | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | 22.07.2011 | - |
| Ohio Wesleyan University | Vorsitzender | - | - |
Karriereverlauf von John Milligan
Ehemalige bekannte Positionen von John Milligan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Direktor/Vorstandsmitglied | 28.01.2016 | 31.12.2018 |
| Vorstandsvorsitzender | 10.03.2016 | 31.12.2018 | |
| Geschäftsführer | 01.01.2007 | 10.03.2016 | |
| Präsident | 01.01.2008 | 31.12.2018 | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Präsident | 13.01.2012 | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.1996 | - |
Ausbildung von John Milligan
| University of Illinois | Doctorate Degree |
| Ohio Wesleyan University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Chairman | 4 |
| Director/Board Member | 3 |
| President | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
- Börse
- Insiders
- John Milligan
- Erfahrung